Study Finds Link Between Antidepressant Use and Type 2 Diabetes in Youth

October 20, 2017

Current use of serotonin reuptake inhibitors among children and adolescents was associated with a nearly two-fold increased risk of developing type 2 diabetes.

Multinational Study Shows Increase in Youth Antidepressant Use

March 10, 2016

International research team, including the School of Pharmacy’s Dr. Julie Zito, publishes new study examining antidepressant prescription rates for individuals ages 0-19 years.

JAMA Study Examines Medicaid Oversight of Antipsychotic Use in Children

March 3, 2015

Study led by PHSR faculty member shows that 31 states have implemented prior authorization policies for atypical antipsychotic prescribing.

PHSR Graduate Students Host First Campus-Wide Interdisciplinary Seminar

May 2, 2014

Dr. William Cooper delivers inaugural lecture spotlighting the field of pharmacoepidemiology.

PHSR Teacher and Mentor Retires from the School of Pharmacy

May 21, 2013

Sheila Weiss, PhD, concludes successful career in academia and embarks on new opportunity in health services industry.

Study Confirms Rise in Antipsychotic Treatment of Medicaid-insured Children

March 15, 2013

More benefit/risk information is needed in community care efforts, says School of Pharmacy researcher.

2012-2013 UM-CERSI Awards Announced

December 7, 2012

The University of Maryland Center of Excellence in Regulatory Science and Innovation (UM-CERSI) recently awarded two Innovation Awards and two Innovations in Minority Health Awards to recognize pioneering research initiatives in regulatory science.

Older Adults Tend Not to Stick With Their Meds Following Heart Attacks

October 10, 2012

New School of Pharmacy study of Medicare patients after heart attacks revealed an overall low exposure to the four medication classes.